Sir Adrian HillKBE FRS FMedSci FRCP | |
---|---|
Born | (1958-10-09) 9 October 1958 (age 66) Dublin, County Dublin, Ireland |
Education | Belvedere College |
Alma mater | |
Known for | Vaccinology |
Spouses |
|
Scientific career | |
Fields | Genetics Immunology Vaccines Malaria |
Institutions | |
Thesis | The distribution and molecular basis of thalassaemia in Oceania (1986) |
Doctoral advisor | John Brian Clegg David Weatherall |
Website | www |
Sir Adrian Vivian Sinton Hill, KBE FRS FMedSci FRCP (born 9 October 1958) is a British-Irish vaccinologist who is Director of the Jenner Institute and Lakshmi Mittal and Family Professor of Vaccinology at the University of Oxford, an honorary Consultant Physician in Infectious Diseases, and Fellow of Magdalen College, Oxford. Hill is a leader in the field of malaria vaccine development and was a co-leader of the research team which produced the Oxford–AstraZeneca COVID-19 vaccine, along with Professor Sarah Gilbert of the Jenner Institute and Professor Andrew Pollard of the Oxford Vaccine Group.
Early life and education
Hill was educated at Belvedere College in Dublin. He began reading medicine at Trinity College Dublin, where he was elected a Foundation Scholar in 1978. Thereupon he transferred to Magdalen College, Oxford for one year, but he ended up remaining in Oxford to complete the rest of his medical degree, qualifying in 1982. He remained at the University of Oxford for postgraduate studies and was awarded a Doctor of Philosophy degree in 1986 for research on the molecular genetics of thalassemia supervised by John B. Clegg [Wikidata].
Career and research
During his time at the Wellcome Trust Centre for Human Genetics his research group studied genetic susceptibility to infections such as malaria, tuberculosis, and HIV. From 1997 he has developed candidate vaccines for malaria which produce cellular (T-cell) immunity and partial efficacy using Adenovirus and Modified vaccinia Ankara (MVA) viral vector vaccines in a prime-boost regime. From 2005 he has played a leading role in the pre-clinical and clinical assessment of new chimpanzee adenoviral vaccine vectors, particularly ChAd63, ChAd3 and ChAdOx1.
His group has developed numerous candidate vaccines against malaria which have been tested in clinical trials in the UK and Africa. In 2021 his group reported high efficacy of a new R21/matrix-M candidate vaccine in Burkina Faso children and this vaccine is now in a phase III licensure trial. In 2014, he led a clinical trial of an Ebola vaccine based on chimpanzee adenoviral and MVA vector technology in response to the West African Ebola virus epidemic. In 2016 he co-founded Vaccitech plc, an Oxford University spin-off company developing therapeutic and preventive vaccines based on viral vector technology. In 2017 he led a successful major award application to Innovate UK to co-found the Vaccines Manufacturing and Innovation Centre (VMIC) in Harwell, Oxfordshire, one of the first purpose-built vaccine manufacturing centres for emergency response vaccines. In response to the 2020 COVID-19 pandemic he worked with many others at Oxford to develop and partner the ChAdOx1 vector-based SARS-CoV-2 vaccine, notably with AstraZeneca and the Serum Institute of India, supporting large scale access for low and middle income countries.
Honours and awards
- 1999 Elected a Fellow of the Royal College of Physicians (FRCP)
- 1999 Elected a Fellow of the Academy of Medical Sciences (FMedSci)
- 2005 Appointed to a Fellowship by Special Election at Magdalen College, Oxford
- 2005 Founded the Jenner Institute at Oxford University and appointed institute Director
- 2008 Elected an Honorary Fellow of Trinity College Dublin (Hon. FTCD)
- 2020 Appointed to an ad hominen Lakshmi Mittal and Family Professorship of Vaccinology at Oxford University
- 2021 Elected a Fellow of the Royal Society
- 2021 Appointed an Honorary Knight Commander of the Order of the British Empire (KBE) in the 2021 Birthday Honours. Made substantive in 2023, which means he can use both the title of 'Sir' and 'KBE'. Prior to this, only the postnominal letters were allowed to be used.
Personal life
Hill has two children with his former wife, epidemiologist Sunetra Gupta.
In 2021, he married Sabina Murray.
References
- ^ Adrian V. S. Hill publications indexed by Google Scholar
- ^ Anon (2020). "Hill, Prof. Adrian Vivian Sinton". Who's Who. A & C Black. doi:10.1093/ww/9780199540884.013.U59812. (Subscription or UK public library membership required.)
- "Adrian Hill". www.ndm.ox.ac.uk. Retrieved 20 July 2021.
- ^ "Professor Adrian Hill, Fellow by Special Election". magd.ox.ac.uk. Retrieved 5 June 2022.
- "Oxford University academics recognised in Queen's Birthday Honours | University of Oxford". www.ox.ac.uk. 11 June 2021. Retrieved 20 July 2021.
- Adrian V. S. Hill publications from Europe PubMed Central
- "List of scholars - Scholars - TCD". www.tcdlife.ie. Retrieved 20 July 2021.
- ^ "Fellows and Scholars 2008". Trinity College Dublin. Retrieved 23 August 2020.
- Hill, Adrian Vivian Sinton (1986). The distribution and molecular basis of thalassaemia in Oceania. bodleian.ox.ac.uk (DPhil thesis). University of Oxford. OCLC 59703987. EThOS uk.bl.ethos.375250.
- "Professor Adrian Hill". oxfordmartin.ox.ac.uk. Oxford Martin School. Archived from the original on 1 February 2016. Retrieved 25 January 2016.
- Schneider, J.; Gilbert, S. C.; Blanchard, T. J.; Hanke, T.; Robson, K. J.; Hannan, C. M.; Becker, M.; Sinden, R.; Smith, G. L.; Hill, A. V. (1998). "Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara". Nature Medicine. 4 (4): 397–402. doi:10.1038/nm0498-397. PMID 9546783. S2CID 11413461.
- ^ "Professor Adrian VS Hill - Nuffield Department of Medicine". ndm.ox.ac.uk. Retrieved 25 January 2016.
- "Adrian Hill: Malaria Vaccines - Nuffield Department of Medicine". ndm.ox.ac.uk. Archived from the original on 11 January 2016. Retrieved 25 January 2016.
- Datoo, M. S.; et al. (May 2021). "Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial". Lancet. 397 (10287): 1809–1818. doi:10.1016/S0140-6736(21)00943-0. PMC 8121760. PMID 33964223.
- University of Oxford (11 March 2016), Oxford London Lecture 2016: Vaccines for Ebola: Tackling a Market Failure, retrieved 17 February 2018
- Oxford Martin School (26 November 2015), Prevent and protect: vaccines and immune responses, retrieved 17 February 2018
- "Our Team - Vaccitech". vaccitech.co.uk. Retrieved 17 February 2018.
- "Dramatic increase in the UK vaccine capability". 3 December 2018.
- "Meet the Irish scientist behind Oxford's coronavirus vaccine". IrishCentral.com. 21 July 2020. Retrieved 11 October 2020.
- ^ "Accelerating vaccine development". royalsociety.org. Retrieved 17 February 2018.
- "Adrian Hill". theconversation.com. The Conversation. 8 August 2013. Retrieved 17 February 2018.
- "Future of Oxford professorship in vaccinology secured with £3.5 million gift University of Oxford".
- "Oxford Researchers elected to Royal Society | University of Oxford". www.ox.ac.uk. 7 May 2021. Retrieved 8 May 2021.
- "Honorary Awards to Foreign Nationals in 2021". Gov.UK. 2021.
- "No. 63999". The London Gazette. 17 March 2023. p. 5218.
- 20th-century British medical doctors
- 21st-century British medical doctors
- 1958 births
- Living people
- People educated at Belvedere College
- Scholars of Trinity College Dublin
- Alumni of Magdalen College, Oxford
- Academics of the University of Oxford
- Fellows of the Academy of Medical Sciences (United Kingdom)
- Fellows of the Royal Society
- Irish knights
- Knights Commander of the Order of the British Empire
- Naturalised citizens of the United Kingdom
- People from Dublin (city)
- NIHR Senior Investigators
- Vaccinologists